7thSpace Interactive (press release) In Assiut study after maximum safe resection of bladder tumor, patients received combined chemo-radiotherapy, 60 Gy of fractionated radiotherapy over 6 weeks, with Cisplatin and Gemcitabine . Results: In Sohag study the age of patients ranged from ...
Windsor Star (blog) Incorrectly labelling these drugs doesn't matter? These drugs – the other was gemcitabine – are used to treat people fighting life-threatening disease: breast cancer, lung cancer, pancreatic cancer, bladder cancer, leukemia, lymphomas. And they're ... and more »
Healio Capecitabine demonstrated encouraging efficacy and toxicity outcomes compared with gemcitabine in a cohort of patients with locally advanced pancreatic cancer, according to phase 2 results of the SCALOP trial. Researchers conducted the open-label, ...
Hamilton Spectator All four Ontario hospitals that received the diluted bags of cyclophosphamide and gemcitabine have appeared before the committee, as well as the company that supplied the doses. “I have quite a few questions to ask (Medbuy),” said Jeff Yurek, a ...
Benzinga Rainier will randomize approximately 130 patients to receive either OGX-427 or placebo in combination with ABRAXANE and gemcitabine therapy. The primary endpo...
Healio Maintenance therapy with paclitaxel and gemcitabine improved PFS and OS in women with metastatic breast cancer who initially exhibited disease control after first-line treatment with six cycles of the same combination, according to results of a phase 3 ...
Sacramento Bee ... Germany, Italy, Spain and the United Kingdom as planned; that CTI may not be able to complete the PIX306 clinical trial of PIXUVRI-rituximab compared to gemcitabine -rituximab in patients who have relapsed after 1 to 3 prior regimens for aggressive ... and more »
RTT News The company expects to complete patient accrual in a phase II trial of OGX-427 in combination with first-line gemcitabine and cisplatin in patients with metastatic bladder cancer in the second half of 2013. Patient enrollment in a phase II trial of OGX ...
NASDAQ The company expects to complete patient accrual in a phase II trial of OGX-427 in combination with first-line gemcitabine and cisplatin in patients with metastatic bladder cancer in the second half of 2013. Patient enrollment in a phase II trial of OGX ... and more »
Healio Capecitabine demonstrated encouraging efficacy and toxicity outcomes compared with gemcitabine in a cohort of patients with locally advanced pancreatic cancer, according to phase 2 results of the SCALOP trial. Researchers conducted the open-label, ...
